Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of BI891065 in Japanese participants
jRCT2080224929Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2019
- Modality
- Small Molecules
01
Overview
Phase 1, single-arm trial of BI 891065 in cancer, sponsored by Boehringer Ingelheim. Started Oct 2019; status: completed.
02
Drugs
BI 891065
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080224929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224929.